The Annual Report of the National Renal Complement Therapeutics Centre 2022/23 [PDF]
Allen G +13 more
core +1 more source
The Annual Report of the National Renal Complement Therapeutics Centre 2021/22 [PDF]
Allen G +11 more
core +1 more source
Successful Birth After First-Trimester Ravulizumab Exposure in a Patient With Paroxysmal Nocturnal Hemoglobinuria: A Case Report. [PDF]
Morioka T +12 more
europepmc +1 more source
First reported case of <i>Moraxella lacunata</i> bacteremia following pharyngitis in an adult with paroxysmal nocturnal hemoglobinemia receiving ravulizumab: A case report. [PDF]
Osawa H, Shibutani K, Mori N.
europepmc +1 more source
Efficacy and Safety of Ravulizumab in IgA Nephropathy: A Phase 2 Randomized Double-Blind Placebo-Controlled Trial [PDF]
Fenoglio, Roberta
core +2 more sources
Advances in Complement Inhibition Therapies for Paroxysmal Nocturnal Hemoglobinuria and Autoimmune Hemolytic Disorders. [PDF]
Tamdin T, Rodgers GM.
europepmc +1 more source
A practical guide for rapid disease modifying therapy initiation and maintenance in aquaporin-4 positive neuromyelitis optica. [PDF]
S G, Pm N, S Y, S B.
europepmc +1 more source
Iptacopan for treating paroxysmal nocturnal haemoglobinuria: A Single Technology Appraisal [PDF]
Alison, Eastwood +8 more
core
Complement Inhibition for Acute Neuromyelitis Optica Spectrum Disorder Attacks: Insights From an International Case Series. [PDF]
Rommer PS +31 more
europepmc +1 more source

